KIR2DL4 Antibody (C-term) Blocking Peptide

Catalog Number: ABT-BP9042B
Article Name: KIR2DL4 Antibody (C-term) Blocking Peptide
Biozol Catalog Number: ABT-BP9042B
Supplier Catalog Number: BP9042b
Alternative Catalog Number: ABT-BP9042B-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Killer cell immunoglobulin-like receptor 2DL4, CD158 antigen-like family member D, G9P, Killer cell inhibitory receptor 103AS, KIR-103AS, MHC class I NK cell receptor KIR103AS, CD158d, KIR2DL4, CD158D, KIR103AS
KIR2DL4 is killer cell immunoglobulin-like receptors (KIRs) which are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC).
NCBI: 3805
UniProt: Q99706
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP9042b was selected from the C-term region of human KIR2DL4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.